Carlos Flores Selected Research

Carlos Flores Research Topics

Disease

25	Sepsis (Septicemia) 11/2023 - 08/2003
21	Asthma (Bronchial Asthma) 12/2021 - 05/2007
11	Infections 02/2024 - 07/2002
11	Acute Lung Injury 12/2015 - 08/2003
9	COVID-19 04/2024 - 08/2020
8	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2023 - 03/2008
8	Lung Injury 11/2014 - 08/2003
7	Ventilator-Induced Lung Injury 12/2015 - 06/2009
6	Pneumonia (Pneumonitis) 04/2024 - 08/2010
6	Angioedema 01/2020 - 01/2014
5	Critical Illness (Critically Ill) 01/2023 - 01/2011
4	Idiopathic Pulmonary Fibrosis 01/2024 - 04/2019
4	Melanoma (Melanoma, Malignant) 03/2023 - 12/2008
4	Urticaria (Hives) 01/2019 - 01/2014
3	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2024 - 01/2021
3	Neoplasms (Cancer) 03/2023 - 10/2006
3	Drug Hypersensitivity (Drug Allergy) 01/2019 - 01/2016
3	Edema (Dropsy) 12/2015 - 01/2011
3	Dent Disease 01/2007 - 11/2003
3	Diabetes Mellitus 07/2004 - 03/2002
2	Hereditary Angioedemas 01/2022 - 10/2020
2	Hypersensitivity (Allergy) 01/2019 - 01/2014
2	Lung Neoplasms (Lung Cancer) 04/2017 - 05/2015
2	Inflammation (Inflammations) 12/2015 - 07/2011
2	Fibrosis (Cirrhosis) 10/2014 - 01/2011
2	Lung Diseases (Lung Disease) 03/2012 - 01/2011
1	Reinfection 12/2023
1	Bacteremia 11/2023
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2023
1	Acute Coronary Syndrome 11/2023
1	COVID-19 related pediatric multisystem inflammatory disease 10/2023
1	Disease Progression 01/2023
1	Mpox (monkeypox) 01/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	Human Influenza (Influenza) 10/2022

Drug/Important Bio-Agent (IBA)

13	Biomarkers (Surrogate Marker)IBA 07/2023 - 07/2007
10	Proteins (Proteins, Gene)FDA Link 05/2022 - 07/2007
7	CytokinesIBA 01/2021 - 08/2003
5	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2021 - 01/2017
5	Myosin-Light-Chain KinaseIBA 10/2015 - 05/2007
4	RNA (Ribonucleic Acid)IBA 02/2021 - 12/2011
4	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019 - 01/2014
3	AutoantibodiesIBA 04/2024 - 01/2021
3	HLA-DQB1 antigen (HLA DQB1)IBA 01/2024 - 12/2021
3	BradykininIBA 10/2020 - 01/2019
3	CollagenIBA 10/2014 - 01/2011
3	CateninsIBA 10/2014 - 01/2011
3	Toll-Like Receptors (Toll-Like Receptor)IBA 10/2010 - 03/2010
3	DNA (Deoxyribonucleic Acid)IBA 07/2008 - 01/2007
2	Arginine (L-Arginine)FDA Link 02/2024 - 01/2003
2	ElementsIBA 02/2024 - 01/2005
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2024 - 07/2023
2	PolymersIBA 03/2023 - 09/2019
2	Interferon Type IIBA 01/2023 - 10/2022
2	KininsIBA 01/2022 - 10/2020
2	Genetic Markers (Genetic Marker)IBA 07/2021 - 01/2019
2	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2019 - 07/2018
2	Immunoglobulin E (IgE)IBA 01/2016 - 01/2012
2	Platelet Endothelial Cell Adhesion Molecule-1IBA 12/2015 - 03/2014
2	EndotoxinsIBA 10/2014 - 07/2007
2	Sphingosine-1-Phosphate ReceptorsIBA 10/2013 - 08/2010
2	Protein Isoforms (Isoforms)IBA 03/2012 - 05/2007
2	Interleukin-1 Receptor-Associated KinasesIBA 02/2012 - 10/2011
2	lipopolysaccharide-binding proteinIBA 10/2009 - 08/2009
2	Codon (Codons)IBA 12/2008 - 01/2005
2	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 03/2008 - 12/2005
2	Glucose (Dextrose)FDA LinkGeneric 01/2003 - 03/2002
1	InterferonsIBA 04/2024
1	Virulence Factors (Pathogenicity Factors)IBA 02/2024
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 12/2023
1	N-(2-cyanoethylene)urea (BA 1)IBA 12/2023
1	HLA-C Antigens (HLA-C)IBA 12/2023
1	HLA-A Antigens (HLA-A)IBA 12/2023
1	HLA-B Antigens (HLA-B)IBA 12/2023
1	Peptides (Polypeptides)IBA 12/2023
1	LipopolysaccharidesIBA 11/2023
1	LipidsIBA 11/2023
1	Proprotein Convertase 9IBA 11/2023
1	alirocumabIBA 11/2023
1	2-5A-dependent ribonuclease (RNase L)IBA 10/2023
1	Xanthine DehydrogenaseIBA 07/2023
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2023
1	pirfenidoneIBA 01/2023
1	Prednisone (Sone)FDA LinkGeneric 01/2023
1	Brentuximab VedotinIBA 01/2023
1	3- (2- methoxyphenyl)- 5- methoxy- 1,3,4- oxadiazol- 2(3H)- oneIBA 01/2023
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2023
1	nintedanibIBA 01/2023
1	P-2 (P 2)IBA 10/2022
1	AntibodiesIBA 10/2022
1	Messenger RNA (mRNA)IBA 05/2022

Therapy/Procedure

10	Artificial Respiration (Mechanical Ventilation) 11/2021 - 08/2006
8	Therapeutics 01/2023 - 05/2015
5	Ligation 01/2015 - 08/2003
4	Critical Care (Surgical Intensive Care) 01/2022 - 03/2008
3	Precision Medicine 01/2023 - 10/2017
3	Mechanical Ventilators (Ventilator) 11/2014 - 08/2007
2	Positive-Pressure Respiration (Positive End-Expiratory Pressure) 06/2009 - 08/2003
1	Immunomodulation 01/2023
1	Drug Therapy (Chemotherapy) 01/2023